A comparison of the efficacy of two interventions to reduce HIV risk behaviors among drug users

AIDS and Behavior

Volumn 15, Issue 8, 2011, Pages 1707-1714

  McCoy, Clyde B ^a   De Gruttola, Victor ^b   Metsch, Lisa ^a   Comerford, Mary ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Behavior change; HIV AIDS; NIDA intervention; RESPECT intervention; Risk behaviors

Indexed keywords

ARTICLE; ATTITUDE TO HEALTH; COMPARATIVE STUDY; CONDOM; COUNSELING; DISEASE TRANSMISSION; DRUG USE; EVALUATION; FEMALE; FOLLOW UP; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVENTION STUDY; MALE; OUTPATIENT DEPARTMENT; PATIENT CARE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK FACTOR; RISK REDUCTION; SEXUAL BEHAVIOR; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

CONDOMS; COUNSELING; DRUG USERS; FEMALE; FLORIDA; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; INTERVENTION STUDIES; MALE; OUTPATIENT CLINICS, HOSPITAL; PATIENT-CENTERED CARE; QUESTIONNAIRES; RISK FACTORS; RISK REDUCTION BEHAVIOR; RISK-TAKING; SEXUAL BEHAVIOR;

EID: 84555205747     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-011-9975-1     Document Type: Article

References (35)

1. Sogolow E, Peersnab G, Semaan S, Strouse D, Lyles C. The HIV/ AIDS Prevention Research Synthesis Project: Scope, methods, and study classification results. J Acquir Immune Defic Syndr. 2002;30(Suppl 1):S15-29. (Pubitemid 34774062)
2. Lyles CM, Kay LS, Crepaz N, et al. Best-evidence interventions: Finding from a systematic review of HIV behavioral interventions for US populations at high risk, 2000-2004. Am J Public Health. 2007;97:133-43. (Pubitemid 46067695)
3. CollinsC,Harshbarger C, Sawyer R, HamdallahM. The diffusion of effective behavioral interventions project: Development, implementation, and lesions learned. AID Educ Prev. 2006;18(Suppl A):5-20. (Pubitemid 44440943)
4. Dworkin SL, Pinto RM, Hunter J, Rapkin B, Remien RH. Keeping the spirit of community partnerships alive in the scale up of HIV/AIDS prevention: Critical reflections on the roll out of DEBI (Diffusion of Effective Behavioral Interventions). Am J Commun Psychol. 2008;42:51-9.
5. DEBI (2007) Diffusion of effective behavioral interventions. http://www.effectiveinterventions.org/. Accessed 5 Nov 2011.
6. Copenhaver M, Johnston B, Lee IC, Harman J, Carey M, Team TSR. Behavioral HIV risk reduction among people who inject drugs: Meta-analytic evidence of efficacy. J Subst Abuse Treat. 2006;31:163-71. (Pubitemid 44223907)
7. Des Jarlais DC, Semaan S. HIV prevention for injecting drug users: The first 25 years and counting. Psychosom Med. 2008;70:606-11.
8. Chitwood DD, Comerford M, Sanchez J. Prevalence and risk factors among sniffers, short-term injectors, and long term injectors of heroin. J Psychoact Drugs. 2003;35:445-53. (Pubitemid 38057470)
9. McCoy CB, Lai S, Metsch L, Messiah SE, Zhao W. Injection drug use and crack cocaine smoking: Independent and dual risk behaviors for HIV infection. Ann Epidemiol. 2004;14:535-42. (Pubitemid 39221231)
10. Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D, Johnson L, Nelson KE. Sex differences in risk factors for HIV seroconversion among injection drug users: A 10-year perspective. Arch Intern Med. 2001;161(10):1281-8. (Pubitemid 32679577)
11. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk factor analysis. Lancet. 2001;357(9266): 1397-401. (Pubitemid 32455367)
12. Kamb ML, Fishbein M, Douglas JM, et al. Efficacy of riskreduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: A randomized controlled trial. JAMA. 1998;280:1161-7. (Pubitemid 28457806)
13. National Institute on Drug Abuse. The standard intervention of the cooperative agreement program for AIDS community-based outreach/intervention research. Cooperative Agreement Steering Committee, January 9-10, 1992.
14. Coyle SL, Needle RH, Normand J. Outreach-based HIV prevention for injection drug users: A review of published outcome data. Public Health Rep. 1998;113(Suppl 1):19-30. (Pubitemid 29330143)
15. Metcalf CA, Douglas JM, Malotte CK, et al. Relative efficacy of prevention counseling with rapid and standard HIV testing: A randomized, controlled trial (RESPECT-2). Sex Transm Dis. 2005;32(2):130-8.
16. Watters JK, Biernacki P. Targeted sampling: Options for the study of hidden populations. Social Probl. 1989;36:416-30.
17. Metsch LR, McCoy CB, Miles CC, Wohler B. Prevention myths and HIV risk reduction by active drug users. AIDS Educ Prev. 2004;16:150-9. (Pubitemid 38544308)
18. Chitwood DD, Inciardi JA, McBride DC, McCoy CB, McCoy HV, Trapido E. A community approach to AIDS intervention. New York: Greenwood Press; 1991.
19. Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ: Prentice-Hall; 1980.
20. Bandura A. Human agency in social cognitive theory. Am Psychol. 1989;44:1175-84.
21. Marmor M, Des Jarlais DC, Cohen H, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS. 1897;1:39-44.
22. Booth RE, Kwiatkowski CF, Chitwood DD. Sex related HIV risk behaviors: Differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug Alcohol Depend. 2000;58:219-26. (Pubitemid 30079672)
23. Chitwood DD, McCoy CB, Comerford M, Kitner K. The prevalence and incidence of HIV among injection drug users: A five year panel study. Popul Res Policy Rev. 1999;18:39-53. (Pubitemid 29524208)
24. Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. New Engl J Med. 1989;321:874-9. (Pubitemid 19238620)
25. Hoffman JA, Klein H, Eber M, Crosby H. Frequency and intensity of crack use as predictors of women's involvement in HIV-related sexual risk behaviors. Drug Alcohol Depend. 1999;58:227-36. (Pubitemid 30079673)
26. Wells EA, Calsyn DA, Saxon AJ, Greenberg DM. Using drugs to facilitate sexual behavior is associated with sexual variety among injection drug users. J Nerv Ment Dis. 1993;181:626-31. (Pubitemid 24259652)
27. Perry JL, Carroll ME. The role of impulsive behavior in drug abuse. Psychopharmacology. 2008;200:1-26.
28. Valdiserri RO, Ogden LL, McCray E. Accomplishments in HIV prevention science: Implications for stemming the epidemic. Nat Med. 2003;9:881-6. (Pubitemid 36889930)
29. Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Rep. 1998;113(Suppl 1):97-106. (Pubitemid 29330151)
30. Friedmann PD, Lemon SC, Stein MD, D'Aunno TA. Accessibility of addiction treatment: Results from a national survey of outpatient substance abuse treatment organizations. Health Serv Res. 2003;38:887-903. (Pubitemid 36682491)
31. Steenrod S, Brisson A, McCarty D, Hodgkin D. Effects of managed care on programs and practices for the treatment of alcohol and drug dependence. Recent Dev Alcohol. 2001;15:51-71.
32. Alexander JA, Nahra TA, Wheeler JRC. Managed care and access to substance abuse treatment services. J Behav Health Serv Res. 2003;30:161-75. (Pubitemid 36397439)
33. Appel PW, Piculell R, Jansky HK, Griffy K. Assessing alcohol and other drug problems (AOD) among sexually transmitted disease (STD) clinic patients with a modified CAGE-A: Implications for AOD intervention services and STD prevention. Am J Drug Alcohol Abuse. 2006;32:129-53.
34. Tsiatis A, Davidian M, Zhang M, Lu X. Covariate adjustment for two-sample treatment comparisons for randomized clinical trials: A principled yet flexible approach. Stat Med. 2008;27:4658-67.
35. Robins J, Rotnitzky A, Zhao L. Estimation of regression coefficients when some regressors are not always observed. J Am Stat Assoc. 1994;89:846-66.